Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers
Sponsor: Mayo Clinic
Summary
This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Official title: Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Hepatobiliary Cancers (ACT-HBC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-05-28
Completion Date
2027-05-30
Last Updated
2025-08-15
Healthy Volunteers
No
Conditions
Interventions
Acceptance and Commitment Therapy
Attend ACT-HBC telehealth group sessions
Questionnaire Administration
Ancillary studies
Telemedicine
Attend ACT-HBC telehealth group sessions
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States